Markets & Stocks
Stay informed about the latest developments and trends in the cannabis stock market with Business of Cannabis. Discover new investment opportunities, market analysis, and more in our stocks category.
Markets & Stocks · page 8
- Markets & Stocks
Celadon’s Funding Woes Continue, DanCann Pharma Partners with Tetra Pharma, & Argent Bio Posts Positive Clinical Trial Results
UK-listed medical cannabis producer Celadon Pharmaceuticals is struggling to emerge from its precarious financial position after months of turmoil.
- Markets & Stocks
Akanda Sells UK’s Canmart as it Pivots Away From Cannabis, Argent Bio Seeks Deals for Malta Facility, & Chill Brands to Raise £1m
Akanda [stock_market_widget type=”chart” template=”line” assets=”AKAN” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Akanda Corp has become the latest listed cannabis company to announce its (partial) exit from the industry as it pivots from medical cannabis cultivation in Europe to telecommunications in South America.
- Markets & Stocks
Organigram Gets Final Investment From Tobacco Giant, Kanabo Sees Double Digit Revenue Increase, & More From Curity Pharma
London Stock Exchange-listed (LSE) UK medical cannabis operator Kanabo has published its broad financial results for 2024, revealing growing revenue and falling losses.
- Markets & Stocks
German Election Results Already Sending Ripples Through Cannabis Market
The results of the German election are already having a ripple effect throughout the market, with the shift in attitudes towards cannabis reform making it a far riskier investment.
- Markets & Stocks
Jazz Pharma Wards Off Epidiolex Patent Challenges, Hellenic Fights for Survival in Court, & OCT Rebrands to Octavian
Earlier this week, Jazz dismissed a patent claim against Apotex, Canada’s largest generic drug producer, as it reached a settlement with the company, the details of which were undisclosed.
- Markets & Stocks
Aurora Posts Record Quarter Thanks to European Medical Growth, Little Green Pharma Acquires Health House, & More From Argent Bio.
Aurora Cannabis [stock_market_widget type=”chart” template=”line” assets=”ACB” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Canadian cannabis giant Aurora Cannabis has seen its stock jump nearly 50% this week after publishing a record-breaking financial performance in its third quarter.
- Markets & Stocks
Aurora & Demecan Launch First German-Grown Products, Stenocare Exits Cultivation Facility, & More From Cantourage
Stenocare Danish medical cannabis oil producer Stenocare has exited its cultivation facility in Denmark, just four years after it was completed.
- Markets & Stocks
Celadon’s Shares Spike as Partnership Starts Generating Revenue, Phillip Morris Expands Cannabis Footprint, & More from DanCann Pharma
Celadon Pharmaceuticals [stock_market_widget type=”chart” template=”line” assets=”CEL.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Celadon Pharmaceuticals has seen its stock price spike this week after revealing that its supply agreement with Danish firm Valeos is now ‘actively contributing to Celadon’s operations.’
- Markets & Stocks
High Tide Breaks into German Market, Cantourage Exceeds Projections in 2024, & More from SEED
Cantourage [stock_market_widget type=”chart” template=”line” assets=”HIGH.DE” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Berlin-based medical cannabis company Cantourage saw sales exceed its own projections in 2024, with sales more than doubling on 2023.
- Markets & Stocks
Tilray Wins Tender to Supply Luxembourg, Argent Biopharma Completes Capital Raise, & More from Stenocare
Argent BioPharma [stock_market_widget type=”chart” template=”line” assets=”RGT.AX” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Argent Biopharma (previously MGC Pharmaceuticals) has completed a US$4.5 million capital raise to support its drug development efforts, just weeks after delisting from the London Stock Exchange.
- Markets & Stocks
BAT Announces 2nd £200m Fund With More Cannabis Investment Expected, Jazz Pharma Looks for New CEO, & Synbiotic Partners With Canna-Tech Firm
British American Tobacco [stock_market_widget type=”chart” template=”line” assets=”BATS.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Tobacco giant British American Tobacco (BAT) has announced the launch of a second investment fund as part of its corporate venture arm, Btomorrow Ventures (BTV).
- Markets & Stocks
First Cannabis Company in History to List on LSE Announces Intention to Leave, Ananda Reaches New Research Milestone & More From Denmark
Argent Biopharma [stock_market_widget type=”chart” template=”line” assets=”RGT.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Argent Biopharma (previously MGC Pharmaceuticals), the first company in history to launch an IPO on the London Stock Exchange, has announced its intention to de-list from the exchange.
